Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $123,498 (100.0% shares, 0.0% debt)

Holdings (26)

AGIO AGIOS PHARMACEUTICALS INC 12.1%
Value ($000) $14,919 Shares 282,443 Est. Cost $51.75 Unrealized -15.8%
SAGE THERAPEUTICS INC 9.9%
Value ($000) $12,272 Shares 266,500 Est. Cost $47.85 Unrealized
FOUNDATION MEDICINE INC 7.8%
Value ($000) $9,690 Shares 415,000 Est. Cost $19.35 Unrealized
EVH EVOLENT HEALTH INC 7.7%
Value ($000) $9,479 Shares 385,000 Est. Cost $17.38 Unrealized +34.5%
BLUEPRINT MEDICINES CORP 6.9%
Value ($000) $8,524 Shares 287,000 Est. Cost $26.00 Unrealized
LOXO ONCOLOGY INC 6.2%
Value ($000) $7,618 Shares 291,000 Est. Cost $27.57 Unrealized
GENMARK DIAGNOSTICS INC 6.0%
Value ($000) $7,375 Shares 625,000 Est. Cost $9.74 Unrealized
SPARK THERAPEUTICS INC 4.5%
Value ($000) $5,616 Shares 93,500 Est. Cost $42.99 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 4.5%
Value ($000) $5,532 Shares 240,000 Est. Cost $18.90 Unrealized
KITE PHARMA INC 4.1%
Value ($000) $5,027 Shares 90,000 Est. Cost $52.91 Unrealized
BLUEBIRD BIO INC 3.3%
Value ($000) $4,067 Shares 60,000 Est. Cost $60.25 Unrealized
CLOVIS ONCOLOGY INC 3.2%
Value ($000) $3,966 Shares 110,000 Est. Cost $13.72 Unrealized
VYGR VOYAGER THERAPEUTICS INC 2.7%
Value ($000) $3,321 Shares 276,500 Est. Cost $17.92 Unrealized
EPIZYME INC 2.4%
Value ($000) $2,903 Shares 295,000 Est. Cost $14.50 Unrealized
EXAS EXACT SCIENCES CORP 2.3%
Value ($000) $2,878 Shares 155,000 Est. Cost $17.62 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.1%
Value ($000) $2,643 Shares 39,000 Est. Cost $83.97 Unrealized -16.0%
MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.1%
Value ($000) $2,634 Shares 200,000 Est. Cost $13.37 Unrealized 0.0%
MYOKARDIA INC 2.1%
Value ($000) $2,614 Shares 160,000 Est. Cost $14.07 Unrealized
GENOMIC HEALTH INC 2.1%
Value ($000) $2,603 Shares 90,000 Est. Cost $28.92 Unrealized
MEDGENICS INC 1.7%
Value ($000) $2,089 Shares 375,000 Est. Cost $5.57 Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.6%
Value ($000) $1,999 Shares 127,500 Est. Cost $15.82 Unrealized -23.5%
IBB ISHARES TR 1.2%
Value ($000) $1,447 Shares 5,000 Est. Cost $289.40 Unrealized
IGNYTA INC 1.0%
Value ($000) $1,227 Shares 195,000 Est. Cost $5.82 Unrealized
IONS IONIS PHARMACEUTICALS INC 1.0%
Value ($000) $1,209 Shares 33,000 Est. Cost $31.29 Unrealized 0.0%
EDIT EDITAS MEDICINE INC 0.9%
Value ($000) $1,152 Shares 85,470 Est. Cost $20.49 Unrealized 0.0%
SYROS PHARMACEUTICALS INC 0.6%
Value ($000) $694 Shares 50,000 Est. Cost $18.16 Unrealized